AviGenics Inc.

Basic Information

111 Riverbend Rd.
411 MASSACHUSETTS AVENUE
Athens, GA, 30605 2613

Company Profile

n/a

Additional Details

Field Value
DUNS: 967296187
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 33


  1. SBIR Phase I: Production of Transgenic Poultry Resistant to Avian Influenza Infection by RNAi

    Amount: $86,302.00

    This Small Business Innovation Research (SBIR) Phase I project generates transgenic poultry resistant to avian influenza (AI) virus through RNA interference (RNAi) technology. Poultry are vulnerable ...

    SBIR Phase I 2007 National Science Foundation
  2. Producing Humanized Therapeutics in Avian Egg White

    Amount: $623,937.00

    DESCRIPTION (provided by applicant): This phase II SBIR project will test the feasibility of producing large amounts of human monoclonal antibody into transchromosomic avian egg white. We will use a ...

    SBIR Phase II 2006 Department of Health and Human Services
  3. Transchromosomic Hens Producing Biotherapeutic Drugs

    Amount: $80,000.00

    Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs i ...

    SBIR Phase I 2006 Department of Agriculture
  4. Protection of Transgenic Poultry from Marek's Disease Virus by RNAi

    Amount: $80,000.00

    MDV is a herpesvirus which causes a lymphoproliferative disorder of domestic chickens. Yearly economic losses from Marek's disease (MD) total $1 billion worldwide and more than $100 million in the U.S ...

    SBIR Phase I 2005 Department of Agriculture
  5. Avian transgenesis via site-directed integration

    Amount: $746,264.00

    DESCRIPTION (provided by applicant): This Phase II SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Chickens are able to ...

    SBIR Phase II 2005 Department of Health and Human Services
  6. Oviduct locus BACs for expression of bio-therapeutics

    Amount: $728,254.00

    DESCRIPTION (provided by applicant): With a daily production of 400 to 2500 milligrams of protein per egg, the chicken ovomucoid and ovalbumin gene loci have the potential to synthesize large amounts ...

    SBIR Phase II 2004 Department of Health and Human Services
  7. Producing humanized therapeutics in quail egg white

    Amount: $91,727.00

    DESCRIPTION (provided by applicant): This project is focused on the development of a novel transgenic avian production platform that will provide human therapeutics in a rapid, cost-effective fashion ...

    SBIR Phase I 2004 Department of Health and Human Services
  8. Avian transgenesis via site-directed integration

    Amount: $90,000.00

    DESCRIPTION (provided by applicant): This SBIR project describes a novel method to create transgenic poultry that will produce biopharmaceutical proteins in their eggs. Poultry, including chicke ...

    SBIR Phase I 2004 Department of Health and Human Services
  9. Ovalbumin locus BACs for expression of biotherapeutics

    Amount: $81,461.00

    DESCRIPTION (provided by applicant): With a daily production capacity of two grams of protein per egg, the chicken ovalbumin gene locus has the potential to synthesize large amounts of biopharmaceutic ...

    SBIR Phase I 2003 Department of Health and Human Services
  10. N/A

    Amount: $69,555.00

    N/A

    SBIR Phase I 2000 Department of Agriculture

Agency Micro-sites

US Flag An Official Website of the United States Government